Semler Scientific, Inc. Q3 FY2023 Earnings Call

· Earnings call transcript and AI-powered summary

  • Total Revenue: $16.3 million in Q3 2023, representing a 16% increase compared to $14.1 million in Q3 2022.
  • Revenue Breakdown:
    • Fixed Fee Revenue: $9.5 million, up 11% year-over-year.
    • Variable Fee Revenue: $6.3 million, up 28% year-over-year, driven by home risk assessments using QuantaFlo.
    • Equipment and Other Revenue: $0.5 million, flat compared to Q3 2022.
  • Operating Expenses: $10 million, up 5% year-over-year, but improved as a percentage of revenue (61% vs. 68% in Q3 2022).
  • Net Income: $5.5 million, up 50% year-over-year from $3.7 million.
  • Earnings Per Share (EPS):
    • Basic: $0.82
    • Diluted: $0.71
  • Cash and Investments: $56 million as of Sept 30, 2023.

Business Highlights & Strategic Initiatives

  • Streamlined Operations: Completed 30% workforce reduction (from 137 in Q2 to 91 in Q3).

Continue Reading

Unlock the full AI-powered summary with key highlights, financial performance, and analyst Q&A.

Upgrade to Professional
Operator: Good afternoon, and welcome to the Semler Scientific 2023 Third Quarter Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note that this event is being recorded. Before we begin, Semler Scientific needs to remind you that certain comments made during this call may constitute forward-looking statements and are made pursuant to and within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 as amended. These include statements regarding the expectations for expansion of the business and the development and marketing of additional products as well as expected savings from the strategic corporate streamlining. Such forward-looking statements are subject to both known and unknown risks and uncertainties that could cause actual results to differ materially from such statements. Those risks and uncertainties are described in the press release and our SEC filings. The forward-looking statements made today are as of the date of this call, and the company does not undertake any obligation to update the forward-looking statements. If you do not have a copy of today’s release, you may obtain on by visiting the Investor Relations page of the website semlerscientific.com. Now I would like to introduce Doug Murphy-Chutorian, CEO of Semler Scientific. Doug Murphy-Chutorian: Good afternoon, everyone. Thank you for joining us for our third quarter 2023 results call. We are aga

Continue Reading

Unlock the full earnings call transcript with speaker labels and formatted dialogue.

Upgrade to Professional